NPCE
NASD NeuroPace, Inc.$13.00 ↑ +0.00 (+0.00%) Trading Up from the previous close of $13.00, $0.02 below the day’s high of $13.02
- YTD change
- -15.80%
- vs 20-day SMA
- -5.20%
- vs 200-day SMA
- -14.64%
Price ranges
Price & Performance
-1.88 (-12.63%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 33.7% away from all-time highs of $19.60
- NPCE is down 16% since the beginning of the year
- NPCE is up 26% over the past 12 months
- NPCE is down 7% over the past 1 month
- 4% of all NPCE investors are betting against NPCE
NPCE reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is +24.0%.
- Previous minute
- +$0.00
- Last hour
- -$0.05
- Last 5 days
- +2.36%
- vs 8-day SMA
- +0.66%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.